Global DDF Summit – Drug Delivery & Formulation
May 18-20, 2026
Berlin, Germany
https://ddfevent.com/live/en/page/home
Subscribe to our press distribution list to receive the latest news about AMW.
May 18-20, 2026
Berlin, Germany
https://ddfevent.com/live/en/page/home
June 22-25, 2026
San Diego, USA
https://convention.bio.org/
July 6-9, 2026
Lisbon, Portugal
https://www.controlledreleasesociety.org/events/crs-2026-annual-meeting-exposition
July 8-10, 2026
Bangkok, Thailand
https://www.cphi.com/sea/en/attend/attend/why-attend.html
October 6-8, 2026
Milan, Italy
https://www.cphi.com/europe/en/exhibit/book-your-stand-milan.html
October 29-30, 2026
Boston, USA
https://poddconference.com/
November 9-11, 2026
Cologne, Germany
https://informaconnect.com/bioeurope/
May 22-24, 2025
Vienna, Austria
September 29 – October 1, 2025
Berlin, Germany
https://ipls.online/events/
October 28-30, 2025
Frankfurt, Germany
https://www.cphi.com/europe/en/home.html
February 5-6, 2026
London, UK
https://pharma-synergy-conference.com/pharmasynergy-2026/
March 2-3, 2026
Lisbon, Portugal
https://www.raucon.com/euro-plx/euro-p-l-x-90
March 23-25, 2026
Lisbon, Portugal
https://informaconnect.com/bioeurope-spring/
March 23-26, 2026
New York City, USA
https://dcatweek.org/
March 23-26, 2026
Prague, Czech Republic
https://worldmeeting.org/
March 24-27, 2026
Munich, Germany
https://analytica.de/de/muenchen/
May 3-7, 2026
Denver, USA
https://www.arvo.org/annual-meeting
Warngau, Germany, May 15, 2024 AMW GmbH, a bio-pharmaceutical company specializing in innovative drug delivery systems, announced today that it has received the final Notified Body Opinion (NBO) report for its leuprorelin implant in prefilled syringes. The NBO completes a diligent conformity review procedure by a notified body, in this case TÜV SÜD. Following official […]
read moreWarngau, Germany, April 11, 2024 AMW GmbH, a specialty bio-pharmaceutical company focused on innovative sustained-release drug delivery systems, was delighted to welcome today the President of the Bavarian State Parliament, Ilse Aigner, to its headquarters in Warngau near Munich, Germany. In her speech to AMW employees, Ms. Aigner acknowledged the Company’s innovative strength and emphasized […]
read moreWarngau, January 9, 2024 AMW GmbH, a specialty bio-pharmaceutical company focused on innovative sustained-release drug delivery systems, today announced that Dr. Joerg Serafimov has been appointed to the newly created role as Chief Business Officer (CBO), effective January 1, 2024. In this capacity, he is responsible for International Business and Licensing, Key Account Management, Business […]
read moreWarngau, Germany, November 28, 2023 AMW GmbH, a specialty pharmaceutical company focused on innovative sustained-release drug delivery systems, today announced the expansion of its leadership team to implement its strategic growth strategy. Following Philipp Karbach taking over the role of Chief Executive Officer (CEO) in June this year, Sebastian Herzog now strengthens the management team […]
read moreWarngau, November 28, 2023 AMW GmbH, a pharmaceutical company specializing in innovative drug delivery systems, today announced the expansion of its management team to implement its strategic growth strategy. After taking over the role of Chief Executive Officer (CEO) from Philipp Karbach in June of this year, Sebastian Herzog is strengthening the management team with […]
read moreYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information